IVI Provides Insight into CVS Health’s Decision to Include Cost-per-QALY Analyses from ICER into Formulary Decision-Making

CVS Health's pharmacy benefit management (PBM) division, CVS Caremark, recently announced their decision to rely exclusively on the analyses of the Institute for Clinical and Economic (ICER) in a new drug management program. IVI's Director of Scientific Communications, Mark Linthicum, responds to this story in MedCity stating, "The neat 'answer' regarding the value of treatment [...]

2018-08-24T13:20:36-04:00August 17th, 2018|News, Viewpoints|

How to Improve Value Assessment

In an op-ed published in Healthcare Business News, IVI's Executive Director, Jennifer Bright, describes four essential steps necessary to better measure value in healthcare: Better value measurement must incorporate the patient perspective into all assessment tools. Real world data must be considered when determining a treatment's worth beyond direct clinical benefit. Value assessments must be [...]

2018-07-27T12:03:59-04:00July 27th, 2018|Viewpoints|

IVI Demonstrates Commitment to Patient Involvement with Release of “Partnering with Patients” Principles

To demonstrate IVI’s commitment to patient involvement and ensure that the patient perspective is represented in our work, IVI recently developed several documents enumerating the principles and practices that guide this vital partnership. These documents offer detail about the actions IVI takes to involve patients and patient organizations early and often in research, model development and other projects, and establish a basis [...]

2018-05-03T16:33:42-04:00April 17th, 2018|News|

IVI Releases Public Feedback on Open-Source Value Project Model for Rheumatoid Arthritis

Today, the Innovation and Value Initiative (IVI) released public feedback on the IVI Open-Source Value Project model for rheumatoid arthritis. IVI launched the Open-Source Value Project, a first-of-its-kind effort to better measure value in health care treatments, with the release of an open-source tool focused on measuring value in treatments for RA. The IVI-RA model [...]

2020-03-19T15:46:03-04:00April 16th, 2018|News, Publications|

IVI-RA Value Tool Featured on ISPOR Student Webinar Series

Devin Incerti, Lead Economist on IVI's Open-Source Value Project, will be presenting the IVI-RA Value Tool as one of ISPOR's featured student webinars. See below for the full description and details on the webinar, as well as the registration link. WEBINAR: Developing Flexible, Iterative, and Transparent Decision Models: A Detailed Look at the Rheumatoid Arthritis [...]

2018-05-03T16:31:29-04:00April 15th, 2018|Events, News|

Patient-Centered Formularies: Steps in the Right Direction, but Challenges Remain

In a post on the IVI-sponsored Health Affairs featured blog series, Drugs and Medical Innovation, Jason Shafrin (IVI Director of Research) and Mark Linthicum (IVI Director of Scientific Communications) explore the role that formularies play in determining value for different stakeholders, and how unique, multi-stakeholder efforts can make formularies more patient-centered. Read the full article [...]

2018-04-16T12:22:51-04:00April 11th, 2018|Viewpoints|

To Get Our Money’s Worth in Healthcare, We Need to Collaborate

In a commentary for Modern Healthcare, IVI Director of Scientific Communications, Mark Linthicum, emphasizes that the healthcare system needs to embrace collaboration to find consensus in the way we measure and pay for health care value. Read the full article here.

2018-01-22T22:29:16-05:00January 22nd, 2018|Viewpoints|

Open-Source Rx Value Model Designed To Encourage ‘More Productive’ Discussions

Pink Sheet Senior Writer, Cathy Kelly, reports on the goals and objectives of the IVI Open-Source Value Project (OSVP), how the first iteration of the tool on rheumatoid arthritis is intended to serve different health care stakeholders, and what the next application will focus on. Kelly quotes IVI Strategic Advisory Panel Chair, Sam Nussbaum, who [...]

2018-03-01T00:11:57-05:00January 22nd, 2018|Press|

IVI’s Mark Linthicum in Morning Consult: Why Understanding Value is Central to True Health Care Reform

Mark Linthicum makes the case that value-based spending should be the focus of health care reform efforts in Washington, D.C. On September 13th health care stakeholders came together at the National Press Club to discuss better approaches to measuring value. Read Full Article Here

2017-11-11T01:18:31-05:00September 20th, 2017|Viewpoints|
Go to Top